Oramed Pharmaceuticals Inc. Stock price
Is Oramed Pharmaceuticals Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,109 stocks worldwide.
Key metrics
Oramed Pharmaceuticals Inc. Stock Analysis
Analyst Opinions
6 Analysts have issued a Oramed Pharmaceuticals Inc. forecast:
Analyst Opinions
6 Analysts have issued a Oramed Pharmaceuticals Inc. forecast:
Don't miss a Thing! We will send you all news about Oramed Pharmaceuticals Inc. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Oramed Pharmaceuticals Inc. Stock News
Company Profile
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in Jerusalem, Israel.
| Head office | United States |
| CEO | Mr. Kidron |
| Employees | 4 |
| Founded | 2002 |
| Website | oramed.com |


